Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the State Budget Gic topic
No spam. Unsubscribe anytime.
State budget pressures force GIC to consider member cost changes and alternative savings levers
Summary
A&F warned of federal tax and program effects and rapidly rising health‑care expenditures; GIC staff presented a menu of levers — from modest co‑pay increases and deductible changes to provider payment methodology, PrudentRx coupon capture, and potential GLP‑1 coverage shifts — for commissioner feedback ahead of December modeling.
Massachusetts’ fiscal outlook and rising health‑care costs are compelling the Group Insurance Commission to examine a broad set of cost‑saving options that could affect member cost sharing, plan design and carrier payment practices.
Chris Marino, Assistant Secretary for Budget at the Executive Office for Administration and Finance, told the GIC the state faces multiple converging fiscal pressures and that federal changes could reduce state tax receipts in FY26. ‘‘We have about $1,300,000,000 in federal budget impacts in FY '26,’’ Marino said, and he noted the federal OB3 action is expected to reduce state tax revenue by roughly $664,000,000 in FY26.
Marino emphasized the scale of health‑care spending growth relative to revenue: while the state expects roughly 2–4% revenue growth, health‑care costs are growing in double digits and have already driven supplemental funding requests to cover MassHealth and state employee health care costs.
With that context, GIC Executive Director Matt walked commissioners through the levers staff can model for FY27. Shorter‑term, member‑facing options include modest increases to urgent‑care co‑pays (proposal example: $20 to $30), higher emergency‑room co‑pays (to market levels), reinstating co‑pays for telehealth mental‑health visits (waived during the pandemic), and raising office‑visit co‑pays and deductibles on commercial plans. Matt said staff will quantify the savings and their distributional impacts before any decision.
Staff also described options aimed at limiting carrier and provider costs without directly increasing member cost share. One proposal is to adopt a uniform methodology for carriers’ out‑of‑network payment to providers (using statutory protections against balance billing to negotiate lower carrier payment rates). Another is PrudentRx, a PBM program that attempts to capture the financial value of manufacturer copay assistance at the point of sale to offset plan drug spend; staff warned the program requires member enrollment in manufacturer assistance programs and that non‑enrollment could expose members to higher out‑of‑pocket bills absent careful outreach.
On prescription coverage, staff again raised GLP‑1 weight‑loss drugs as a major budgetary pressure. ‘‘I continue to believe that we should continue to cover those drugs,’’ Matt said, while acknowledging other plan sponsors are removing coverage and that the policy tradeoffs raise equity concerns because those able to pay cash would continue access.
Commissioners pressed staff for additional modeling and cross‑state comparisons: several asked staff to analyze reference‑based pricing and other state models (Oregon, Maryland, Vermont) and requested utilization, cost and population breakdowns (e.g., urgent care and ER usage, the demographic profile of members who might lose coverage under certain levers). Commissioners emphasized protecting low‑income and vulnerable members if benefit changes are pursued.
What’s next: staff will return with modeling on each lever, distributional impacts, interactions among options (for example, how PrudentRx would interact with Vida/behavioral‑health programs and GLP‑1 coverage), and comparison data from other states for the December meeting.
Sources: Presentation and Q&A with Chris Marino (A&F) and Matt (GIC Executive Director).
